Passage Bio

PASG

PASG Passage Bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    PASG Chart
    See on advanced chart >

    About

    Passage Bio, Inc., a Delaware corporation incorporated in July 26, 2017, is a genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system diseases.Their vision is to become the premier genetic medicines...
    • Highlight
      A clinical-stage genetic medicines company that develops therapies for the treatment of rare monogenic central nervous system diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/28/2020
    • Established Date
      07/26/2017
    • Full-time Employees
      58
    • Address
      One Commerce Square 2005 Market Street 39th Floor Philadelphia PA 19103
    • Tel
      1-267-8660311
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-23 11:09:37